Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Mahmood Nadir sold 6,500 shares at $31.71 ($206,115)
  2. 4 Open-market sale Chief Executive Officer sold 8,500 shares at an average $26.61 ($226,219)
  3. 4 Exercise or conversion Mahmood Nadir acquired 1,800 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Brandenberger Ralph sold 4,140 shares at $24.50 ($101,430)
  12. 4 Open-market sale Mahmood Nadir sold 3,000 shares at $27.16 ($81,480)
  13. 4 Open-market sale Chief Scientific Officer sold 3,600 shares at $31.64 ($113,904)
  14. 4 Other acquisition Director acquired 568,033 shares (other)
  15. 4 Open-market sale Mahmood Nadir sold 3,500 shares at $32.70 ($114,450)
  16. 4 Open-market sale Chief Executive Officer sold 17,000 shares at an average $30.74 ($522,540)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Scientific Officer sold 6,400 shares at an average $39.25 ($251,229)
  19. 4 Open-market sale Mahmood Nadir sold 5,500 shares at an average $48.57 ($267,120)
  20. 4 Exercise or conversion Mahmood Nadir acquired 3,083 shares (option exercise)

Page 8 of 11 · 218 filings